Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

19.46
Delayed Data
As of Feb 23
 -0.25 / -1.27%
Today’s Change
14.85
Today|||52-Week Range
33.30
-4.79%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close19.71
Today’s open19.86
Day’s range19.13 - 20.01
Volume135,752
Average volume (3 months)276,842
Market cap$686.6M
Dividend yield--
Data as of 4:00pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-137.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
ACIUAC Immune Ltd+0.02+0.16%
VSARVersartis Inc+1.60+8.21%
ACRSAclaris Therapeutics...+2.33+8.57%
PGNXProgenics Pharmaceut...+0.13+1.29%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs